Filing Details

Accession Number:
0000914190-15-000204
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-05-05 17:01:10
Reporting Period:
2015-05-01
Filing Date:
2015-05-05
Accepted Time:
2015-05-05 17:01:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1180145 Cardiovascular Systems Inc CSII Surgical & Medical Instruments & Apparatus (3841) 411698056
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1358186 G Brent Blackey 1225 Old Highway 8 Nw
St. Paul MN 55112
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-05-01 2,500 $29.38 57,145 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $7.90 2017-10-08 38,820 38,820 Direct
Common Stock Stock Option (right to buy) $7.90 2017-10-08 6,470 6,470 Direct
Common Stock Restricted Stock Units $0.00 5,714 5,714 Direct
Common Stock Restricted Stock Units $0.00 11,628 11,628 Direct
Common Stock Restricted Stock Units $0.00 21,739 21,739 Direct
Common Stock Restricted Stock Units $0.00 7,192 7,192 Direct
Common Stock Restricted Stock Units $0.00 10,917 10,917 Direct
Common Stock Restricted Stock Units $0.00 2015-08-13 2015-08-13 2,749 2,749 Direct
Common Stock Restricted Stock Units $0.00 4,580 4,580 Direct
Common Stock Restricted Stock Units $0.00 2016-08-31 2016-08-31 2,045 2,045 Direct
Common Stock Restricted Stock Units $0.00 4,260 4,260 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2017-10-08 38,820 38,820 Direct
2017-10-08 6,470 6,470 Direct
5,714 5,714 Direct
11,628 11,628 Direct
21,739 21,739 Direct
7,192 7,192 Direct
10,917 10,917 Direct
2015-08-13 2,749 2,749 Direct
4,580 4,580 Direct
2016-08-31 2,045 2,045 Direct
4,260 4,260 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $29.32 to $29.40 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. Fully exercisable.
  3. Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership.
  4. Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of Company common stock on the payment date.
  5. Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment, and shall be payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 1,065 on each of September 30, 2014, December 31, 2014, March 31, 2015 and June 30, 2015.